{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:43:17Z","timestamp":1793742197779,"version":"4.6.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research Fellowship","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Association of Hemophilia Clinic Directors of Canada (AHCDC)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.blre.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T21:33:52Z","timestamp":1471728832000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Genetic diagnosis in hemophilia and von Willebrand disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Laura L.","family":"Swystun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula D.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2016.08.003_bb0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I","article-title":"Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators","volume":"59","author":"Soucie","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2016.08.003_bb0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.blre.2016.08.003_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0025","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.blre.2016.08.003_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.blre.2016.08.003_bb0035","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2016.08.003_bb0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/humu.20208","article-title":"Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A","volume":"26","author":"Bogdanova","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.blre.2016.08.003_bb0045","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/j.1460-2075.1986.tb04435.x","article-title":"Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit","volume":"5","author":"Verweij","year":"1986","journal-title":"EMBO J"},{"key":"10.1016\/j.blre.2016.08.003_bb0050","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/312326a0","article-title":"Characterization of the human factor VIII gene","volume":"312","author":"Gitschier","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.blre.2016.08.003_bb0055","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1073\/pnas.79.21.6461","article-title":"Isolation and characterization of a cDNA coding for human factor IX","volume":"79","author":"Kurachi","year":"1982","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2016.08.003_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.2448875","article-title":"Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase","volume":"239","author":"Saiki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.blre.2016.08.003_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/asheducation-2015.1.152","article-title":"Using genetic diagnostics in hemophilia and von Willebrand disease","volume":"2015","author":"Swystun","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2016.08.003_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2006.01361.x","article-title":"Genetic risk factors for inhibitors to factors VIII and IX","volume":"12","author":"Oldenburg","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0075","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1538-7836.2009.03615.x","article-title":"Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia a patients with high-responding inhibitors","volume":"7","author":"Coppola","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0080","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1160\/TH12-02-0108","article-title":"Survey of laboratory tests used in the diagnosis and evaluation of haemophilia a","volume":"109","author":"Gomez","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0085","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12908","article-title":"Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders","volume":"22","author":"Bastida","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0090","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2015-12-688267","article-title":"A comprehensive high-throughput sequencing test for the diagnosis of inherited bleeding, thrombotic and platelet disorders","volume":"127","author":"Simeoni","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2141.2010.08400.x","article-title":"First application of MLPA method in severe von Willebrand disease. Confirmation of a new large VWF gene deletion and identification of heterozygous carriers","volume":"152","author":"Cabrera","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2016.08.003_bb0100","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/j.1538-7836.2012.04843.x","article-title":"Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening","volume":"10","author":"Payne","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/hae.12424","article-title":"Genomics of bleeding disorders","volume":"20","author":"Goodeve","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0110","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V92.4.1458","article-title":"Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A","volume":"92","author":"Liu","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2016.08.003_bb0120","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1373\/clinchem.2004.046490","article-title":"Genotyping the hemophilia inversion hotspot by use of inverse PCR","volume":"51","author":"Rossetti","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.blre.2016.08.003_bb0125","first-page":"261","article-title":"The UK National External Quality Assessment Scheme for heritable bleeding disorders","volume":"1","author":"Perry","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0130","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jth.12958","article-title":"Hemophilia B: molecular pathogenesis and mutation analysis","volume":"13","author":"Goodeve","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0135","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1538-7836.2009.03346.x","article-title":"Molecular mechanisms underlying hemophilia A phenotype in seven females","volume":"7","author":"Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-09-3879","article-title":"Bleeding in carriers of hemophilia","volume":"108","author":"Plug","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0145","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1182\/blood-2006-06-026104","article-title":"A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels","volume":"109","author":"Viel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0150","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/jth.13144","article-title":"Complexity and diversity of F8 genetic variations in the 1000 genomes","volume":"13","author":"Li","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0155","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1538-7836.2003.00088.x","article-title":"Molecular mechanisms of mild and moderate hemophilia A","volume":"1","author":"Jacquemin","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0160","author":"Rallapalli"},{"key":"10.1016\/j.blre.2016.08.003_bb0165","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.3390\/ijms12107271","article-title":"Eighteen years of molecular genotyping the hemophilia inversion hotspot: from Southern blot to inverse shifting-PCR","volume":"12","author":"Rossetti","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2016.08.003_bb0170","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/hmg\/3.7.1035","article-title":"Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells","volume":"3","author":"Rossiter","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.blre.2016.08.003_bb0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.V99.1.168","article-title":"Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A","volume":"99","author":"Bagnall","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5482\/HAMO-13-08-0043","article-title":"F8 genetic analysis strategies when standard approaches fail","volume":"34","author":"Pezeshkpoor","year":"2014","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.blre.2016.08.003_bb0185","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"Palla","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0190","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1538-7836.2011.04408.x","article-title":"Deep intronic variations may cause mild hemophilia A","volume":"9","author":"Castaman","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0195","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/jth.12339","article-title":"Deep intronic \u201cmutations\u201d cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA","volume":"11","author":"Pezeshkpoor","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0200","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1160\/TH14-12-1011","article-title":"Identification of deep intronic variants in 15 haemophilia A patients by next generation sequencing of the whole factor VIII gene","volume":"114","author":"Bach","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0205","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0210","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2013-02-483263","article-title":"Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A","volume":"122","author":"Eckhardt","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0215","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3270","article-title":"Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A","volume":"19","author":"Pandey","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2016.08.003_bb0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2516.2007.01437.x","article-title":"F8 gene mutation profile and ITT response in a cohort of Italian haemophilia A patients with inhibitors","volume":"13","author":"Salviato","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0225","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2006-05-024711","article-title":"Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A","volume":"108","author":"Astermark","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1538-7836.2007.02290.x","article-title":"Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A","volume":"5","author":"Astermark","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0235","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2005-09-3918","article-title":"Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A","volume":"107","author":"Astermark","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0240","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1655944","article-title":"HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party","volume":"77","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0245","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2015-12-685735","article-title":"Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients","volume":"127","author":"Gorski","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0250","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/bi00335a049","article-title":"Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)","volume":"24","author":"Yoshitake","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.blre.2016.08.003_bb0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tig.2013.09.007","article-title":"Hemophilia B Leyden and once mysterious cis-regulatory mutations","volume":"30","author":"Funnell","year":"2014","journal-title":"Trends Genet"},{"key":"10.1016\/j.blre.2016.08.003_bb0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/345444a0","article-title":"Disruption of a C\/EBP binding site in the FIX promoter is associated with haemophilia B","volume":"345","author":"Crossley","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.blre.2016.08.003_bb0265","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1073\/pnas.89.14.6300","article-title":"Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden","volume":"89","author":"Reijnen","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2016.08.003_bb0270","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ajhg.2013.02.003","article-title":"A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden","volume":"92","author":"Funnell","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.blre.2016.08.003_bb0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.1631558","article-title":"Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter","volume":"257","author":"Crossley","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.blre.2016.08.003_bb0280","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1538-7836.2008.02940.x","article-title":"A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter +13A>G)","volume":"6","author":"James","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0285","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1365-2516.2008.01853.x","article-title":"Familial deficiency of vitamin K-dependent clotting factors","volume":"14","author":"Weston","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0290","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<267::AID-HUMU11>3.0.CO;2-I","article-title":"Deep intronic mutations are rarely a cause of hemophilia B","volume":"14","author":"Feng","year":"1999","journal-title":"Hum Mutat"},{"key":"10.1016\/j.blre.2016.08.003_bb0295","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2516.2008.01753.x","article-title":"Why does the mutation G17736A\/Val107Val (silent) in the F9 gene cause mild haemophilia B in five Swedish families?","volume":"14","author":"Knobe","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0300","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1182\/blood.V116.21.2197.2197","article-title":"The synonymous V107V mutation in Factor IX is not so silent and may cause hemophilia B in patients","volume":"116","author":"Kimchi-Sarfaty","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0305","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/hae.12553","article-title":"Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B","volume":"21","author":"Saini","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0310","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1365-2516.2009.02039.x","article-title":"Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997\u20132006)","volume":"15","author":"Chitlur","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0315","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2016.08.003_bb0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105.","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0325","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0330","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0335","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH12-02-0089","article-title":"Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients","volume":"108","author":"Yadegari","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0340","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0345","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood-2002-12-3693","article-title":"Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease","volume":"102","author":"O'Brien","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0350","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2012-12-471672","article-title":"No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation","volume":"121","author":"Flood","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0355","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0360","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood-2013-02-485094","article-title":"Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project","volume":"122","author":"Johnsen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0365","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0370","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0375","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0380","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE","volume":"115","author":"Schneppenheim","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0385","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood-2005-04-1758","article-title":"Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis","volume":"107","author":"Hassenpflug","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0390","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2009-11-253120","article-title":"Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions","volume":"115","author":"Golder","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0395","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0400","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12117","article-title":"Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease","volume":"19","author":"Larsen","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0405","doi-asserted-by":"crossref","first-page":"e33-e33","DOI":"10.1111\/j.1365-2516.2011.02676.x","article-title":"A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain","volume":"18","author":"Keeling","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0410","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2014-11-610824","article-title":"Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0415","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0420","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0038-1650401","article-title":"Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques","volume":"75","author":"Nesbitt","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0425","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jth.12130","article-title":"The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles","volume":"11","author":"Bowman","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0430","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2016.08.003_bb0435","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2516.2009.02059.x","article-title":"The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England","volume":"15","author":"Sutherland","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0440","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-10-462085","article-title":"Alloantibodies in von Willebrand disease","volume":"122","author":"James","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0445","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0450","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0455","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence VWF and FVIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0460","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2016.08.003_bb0465","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1073\/pnas.1219885110","article-title":"Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association","volume":"110","author":"Desch","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2016.08.003_bb0470","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/jth.12927","article-title":"CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease","volume":"13","author":"Sanders","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0475","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0033-1353442","article-title":"Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect","volume":"39","author":"Othman","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0480","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4613-0331-2_7","article-title":"Antibodies to von Willebrand factor in von Willebrand disease","volume":"386","author":"Mannucci","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.blre.2016.08.003_bb0485","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2516.2008.01679.x","article-title":"Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis","volume":"14","author":"Iorio","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0490","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1538-7836.2008.03107.x","article-title":"An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary","volume":"6","author":"Mohl","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0495","first-page":"150","article-title":"Use of recombinant Factor VIla (NovoSeven\u00ae) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor","volume":"26","author":"Ciavarella","year":"1996","journal-title":"Haemostasis"},{"key":"10.1016\/j.blre.2016.08.003_bb0500","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/j.1365-2516.2012.02799.x","article-title":"The challenging management of a child with type 3 von Willebrand disease (VWD) and antibodies to von Willebrand factor (VWF)","volume":"18","author":"Pergantou","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2016.08.003_bb0505","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.blre.2016.08.003_bb0510","first-page":"1","article-title":"Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics","author":"Wallis","year":"2013","journal-title":"Assoc Clin Genet Sci"},{"key":"10.1016\/j.blre.2016.08.003_bb0515","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/jth.12276","article-title":"An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B","volume":"11","author":"Rallapalli","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0520","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2141.2000.01834.x","article-title":"Intracellular accumulation of factor VIII induced by missense mutations Arg593Cys and Asn 618Ser explains cross-reacting material-reduced haemophilia A","volume":"108","author":"Roelse","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2016.08.003_bb0525","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2009.03486.x","article-title":"Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study","volume":"7","author":"Eikenboom","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2016.08.003_bb0530","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood-2013-09-521484","article-title":"Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and \u03b12\u03b21-mediated collagen binding in thrombus formation","volume":"124","author":"Shida","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0535","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood-2010-08-303727","article-title":"Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models","volume":"117","author":"Pruss","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0540","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2012-06-435727","article-title":"Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells","volume":"121","author":"Starke","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0545","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2012-06-434373","article-title":"Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease","volume":"121","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2016.08.003_bb0550","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.blre.2016.08.003_bb0555","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.blre.2016.08.003_bb0560","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.blre.2016.08.003_bb0565","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.185.4154.862","article-title":"Amino acid difference formula to help explain protein evolution","volume":"185","author":"Grantham","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.blre.2016.08.003_bb0570","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/humu.21445","article-title":"Performance of mutation pathogenicity prediction methods on missense variants","volume":"32","author":"Thusberg","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.blre.2016.08.003_bb0575","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00439-013-1396-y","article-title":"Molecular genetic epidemiology of human diseases: from patterns to predictions","volume":"133","author":"Knecht","year":"2014","journal-title":"Hum Genet"},{"key":"10.1016\/j.blre.2016.08.003_bb0580","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrg1617","article-title":"Haemophilia A: from mutation analysis to new therapies","volume":"6","author":"Graw","year":"2005","journal-title":"Nat Rev Genet"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T20:11:24Z","timestamp":1657138284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X16300534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0268960X16300534"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2016.08.003","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic diagnosis in hemophilia and von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}